These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35644621)

  • 1. Grading of IDH-mutant astrocytoma using diffusion, susceptibility and perfusion-weighted imaging.
    Yang X; Xing Z; She D; Lin Y; Zhang H; Su Y; Cao D
    BMC Med Imaging; 2022 May; 22(1):105. PubMed ID: 35644621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of Ki-67 labeling index, ATRX mutation, and MGMT promoter methylation status in IDH-mutant astrocytoma by morphological MRI, SWI, DWI, and DSC-PWI.
    Yang X; Hu C; Xing Z; Lin Y; Su Y; Wang X; Cao D
    Eur Radiol; 2023 Oct; 33(10):7003-7014. PubMed ID: 37133522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting 1p/19q codeletion status using diffusion-, susceptibility-, perfusion-weighted, and conventional MRI in IDH-mutant lower-grade gliomas.
    Yang X; Lin Y; Xing Z; She D; Su Y; Cao D
    Acta Radiol; 2021 Dec; 62(12):1657-1665. PubMed ID: 33222488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semiquantitative assessment of intratumoral susceptibility signals using non-contrast-enhanced high-field high-resolution susceptibility-weighted imaging in patients with gliomas: comparison with MR perfusion imaging.
    Park MJ; Kim HS; Jahng GH; Ryu CW; Park SM; Kim SY
    AJNR Am J Neuroradiol; 2009 Aug; 30(7):1402-8. PubMed ID: 19369602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive Assessment of
    Xing Z; Yang X; She D; Lin Y; Zhang Y; Cao D
    AJNR Am J Neuroradiol; 2017 Jun; 38(6):1138-1144. PubMed ID: 28450436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IDH genotypes differentiation in glioblastomas using DWI and DSC-PWI in the enhancing and peri-enhancing region.
    Xing Z; Zhang H; She D; Lin Y; Zhou X; Zeng Z; Cao D
    Acta Radiol; 2019 Dec; 60(12):1663-1672. PubMed ID: 31084193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of apparent diffusion coefficient in the grading of adult isocitrate dehydrogenase-mutant astrocytomas: relationship with the Ki-67 proliferation index.
    She Y; Liu X; Jiang J; Wang X; Niu Q; Zhou J
    Acta Radiol; 2024 May; 65(5):489-498. PubMed ID: 38644751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined value of susceptibility-weighted and perfusion-weighted imaging in assessing who grade for brain astrocytomas.
    Wang XC; Zhang H; Tan Y; Qin JB; Wu XF; Wang L; Zhang L
    J Magn Reson Imaging; 2014 Jun; 39(6):1569-74. PubMed ID: 24987755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiating IDH-mutant astrocytomas and 1p19q-codeleted oligodendrogliomas using DSC-PWI: high performance through cerebral blood volume and percentage of signal recovery percentiles.
    Pons-Escoda A; Garcia-Ruiz A; Naval-Baudin P; Martinez-Zalacain I; Castell J; Camins A; Vidal N; Bruna J; Cos M; Perez-Lopez R; Oleaga L; Warnert E; Smits M; Majos C
    Eur Radiol; 2024 Aug; 34(8):5320-5330. PubMed ID: 38282078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IDH mutant and 1p/19q co-deleted oligodendrogliomas: tumor grade stratification using diffusion-, susceptibility-, and perfusion-weighted MRI.
    Lin Y; Xing Z; She D; Yang X; Zheng Y; Xiao Z; Wang X; Cao D
    Neuroradiology; 2017 Jun; 59(6):555-562. PubMed ID: 28474187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of perfusion- and diffusion-weighted imaging to differentiate between pilocytic astrocytomas and high-grade gliomas: a multicenter study in Japan.
    Kikuchi K; Hiwatashi A; Togao O; Yamashita K; Kamei R; Kitajima M; Kanoto M; Takahashi H; Uchiyama Y; Harada M; Shinohara Y; Yoshiura T; Wakata Y; Honda H
    Neuroradiology; 2018 Apr; 60(4):391-401. PubMed ID: 29450601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiparametric Framework Magnetic Resonance Imaging Assessment of Subtypes of Intracranial Germ Cell Tumors Using Susceptibility Weighted Imaging, Diffusion-Weighted Imaging, and Dynamic Susceptibility-Contrast Perfusion-Weighted Imaging Combined With Conventional Magnetic Resonance Imaging.
    Li Y; Wang P; Zhang J; Li J; Chen L; Qiu X
    J Magn Reson Imaging; 2022 Oct; 56(4):1232-1242. PubMed ID: 35278008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive prediction of p53 and Ki-67 labelling indices and O-6-methylguanine-DNA methyltransferase promoter methylation status in adult patients with isocitrate dehydrogenase wild-type glioblastomas using diffusion-weighted imaging and dynamic susceptibility contrast-enhanced perfusion-weighted imaging combined with conventional MRI.
    Xing Z; Huang W; Su Y; Yang X; Zhou X; Cao D
    Clin Radiol; 2022 Aug; 77(8):e576-e584. PubMed ID: 35469666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DSC-PWI presurgical differentiation of grade 4 astrocytoma and glioblastoma in young adults: rCBV percentile analysis across enhancing and non-enhancing regions.
    Pons-Escoda A; Naval-Baudin P; Viveros M; Flores-Casaperalta S; Martinez-Zalacaín I; Plans G; Vidal N; Cos M; Majos C
    Neuroradiology; 2024 Aug; 66(8):1267-1277. PubMed ID: 38834877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasively evaluating the grade and IDH mutation status of gliomas by using mono-exponential, bi-exponential diffusion-weighted imaging and three-dimensional pseudo-continuous arterial spin labeling.
    Guo D; Jiang B
    Eur J Radiol; 2023 Mar; 160():110721. PubMed ID: 36738600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative vs. semiquantitative assessment of intratumoral susceptibility signals in patients with different grades of glioma.
    Bhattacharjee R; Gupta RK; Patir R; Vaishya S; Ahlawat S; Singh A
    J Magn Reson Imaging; 2020 Jan; 51(1):225-233. PubMed ID: 31087724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Static
    Song S; Wang L; Yang H; Shan Y; Cheng Y; Xu L; Dong C; Zhao G; Lu J
    Eur Radiol; 2021 Jun; 31(6):4087-4096. PubMed ID: 33211141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular differences between IDH-wildtype glioblastoma and astrocytoma IDH-mutant grade 4 at imaging and transcriptomic levels.
    Álvarez-Torres MDM; López-Cerdán A; Andreu Z; de la Iglesia Vayá M; Fuster-Garcia E; García-García F; García-Gómez JM
    NMR Biomed; 2023 Nov; 36(11):e5004. PubMed ID: 37482922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation between supratentorial pilocytic astrocytoma and extraventricular ependymoma using multiparametric MRI.
    Zhou X; Su Y; Huang W; Lin X; Xing Z; Cao D
    Acta Radiol; 2022 Dec; 63(12):1661-1668. PubMed ID: 34709088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR imaging phenotype correlates with extent of genome-wide copy number abundance in IDH mutant gliomas.
    Wu CC; Jain R; Neto L; Patel S; Poisson LM; Serrano J; Ng V; Patel SH; Placantonakis DG; Zagzag D; Golfinos J; Chi AS; Snuderl M
    Neuroradiology; 2019 Sep; 61(9):1023-1031. PubMed ID: 31134296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.